Features of the Lipid Profile in Patients after Acute Pulmonary Embolism
Open Access
- 27 August 2025
- journal article
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 24 (4) , 55-66
Abstract
Introduction. The question of the effect of lipids on the risk of venous thromboembolism (VTE) currently remains open and debatable. The effect of dyslipidemia on the risk of arterial and venous thrombosis is currently being studied.The aim of the work was to evaluate the parameters of the blood lipids of patients with pulmonary embolism (PE) in the acute period and 1 year after the episode.Materials and methods. A prospective cohort study of lipids — total cholesterol (TCH), low-density lipoproteins (LDL-C), high-density lipoproteins (HDL-C), triglycerides (TG), apolipoproteins A1and B (ApoA1 and ApoB) — was conducted in patients in the acute period PE and after 1 year of follow-up.Results. Patients with PE in the acute period have initially normal levels of THC, LDL-C, TG, ApoA1, ApoB, and low levels of HDL-C. After 1 year of follow-up, the levels of THC, LDL-C, TG, and ApoB exceed normal values, dyslipidemia is detected due to the predominance of LDL-C, and HDL-C levels return to normal.Discussion. Determination of the blood lipids initially and over time allows monitoring changes in the concentration of lipids and correcting dyslipidemia to reduce cardiovascular risk.Conclusion. In the acute period of PE, normal levels of THC, LDL-C, TG, ApoA1, ApoB are noted, but lower in comparison with patients without a history of VTE, low levels of HDL-C. After a year of follow-up, hypercholesterolemia, dyslipidemia due to LDL-C, TG, and ApoB are detected, which creates a cardiovascular risk in these patients and requires correction.Keywords
This publication has 25 references indexed in Scilit:
- Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”Thrombosis and Haemostasis, 2023
- Causal Associations Between Cardiovascular Risk Factors and Venous ThromboembolismSeminars in Thrombosis and Hemostasis, 2023
- Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: Association with lipoproteins and C-reactive proteinVascular Pharmacology, 2022
- Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTECochrane Database of Systematic Reviews, 2021
- Plasma fibrin clot proteomics in patients with acute pulmonary embolism: Association with clot propertiesJournal of Proteomics, 2020
- Arterial and venous thrombosis: What's the link? A narrative reviewThrombosis Research, 2020
- Lipoprotein(a) is not associated with venous thromboembolism riskScandinavian Cardiovascular Journal, 2019
- Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trialsAtherosclerosis, 2018
- Association of Serum Cholesterol Levels with Short-term Mortality in Patients with Acute Pulmonary EmbolismHeart, Lung and Circulation, 2016
- Asociación entre enfermedad tromboembólica venosa y dislipidemiaMedicina Clinica, 2014